BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$69.13 USD
-1.56 (-2.21%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $69.01 -0.12 (-0.17%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Cash and Equivalents (Quarterly)
The Quarterly Cash and Equivalents are the most liquid current assets found on the company's balance sheet. Cash equivalents are short-term commitments that can be turned into hard cash easily.
BMRN 69.13 -1.56(-2.21%)
Will BMRN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BMRN based on the 1-3 month trading system that more than doubles the S&P 500.